| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Outsourcing > Outsourced Debt Collections for Medical Practice - Top 5 Criteria to Better Billing Performance |
|
Advice You - Outsourced Debt Collections for Medical Practice - Top 5 Criteria to Better Billing Performance
Debt collection from patients is a conflict doctors often prefer avoiding for fear of potential implications to practice reputation and increased exposure to malpractice lawsuits. Healthcare debt collections require unique combination of sensitivity, skill, and discipline. Understanding of debt collections process and outsourcing opportunities help the practice owner improve revenue cycle while m According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product inimizing practice risks. The best way to improve the patient payment component of the revenue cycle is to collect cash payment in advance for healthcare services. However, without solid processes and disciplined implementation, upfront cash collection can challenge and frustrate front office staff, often contributing to accumulation of outstanding patient debt. Insurance companies sending paymen ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ts directly to patients instead of the office further exacerbate the difficulties of debt collection. A typical debt-processing scenario proceeds in three phases, starting with billing, to debt accumulation, to selection of the most appropriate collections method. Clear definition of responsibilities along with payment arrangements help effective collections, minimize practice risks, and reduce adm lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. inistration costs. Billing Phase: Your billing office sends patient invoices and a number of reminder invoices regarding outstanding balance directly to the patient. Debt Accumulation Phase: The patient does not pay the invoice for a time period exceeding desired limit (typically, 90-120 days). Accounts receivable distribution over the span of 30, 60, 90, and 120 days takes the sha here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e of inverted horizontal S. Debt Collections Phase: The practice must consider at least four alternatives for outstanding debt collection:
First, dismiss d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ing a patient is not always an appropriate option because of associated reputation implications and potential medical malpractice risk. More importantly, dismissing the patient only stops subsequent debt accumulation but does not eliminate the already accumulated debt. Next, financial hardship write-off may not be feasible as some patients refuse or are ineligible for it. Third, a small court can ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc help collections only from patients with steady work and debt under $5,000, upon paying a typical $75 processing fee. Keep in mind that a small court limits its scope to liens and/or wage garnishments instead of actually making collections. Finally, a specialized collection agency with thorough understanding of the claim payment process and result-oriented and accountable approach to customer servi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e recovers on average 15% of outstanding debt. Key debt collections agency selection issues revolve around industry knowledge, performance, control, costs, and interaction between billing and collections services:
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically collections regulations.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ rge debt cases in court
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi rmance including percent collected and time to account liquidation.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ilable over a secure Internet connection 24 x7.
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod indemnify your practice from lawsuits resulting from collection efforts through a written hold-harmless agreement.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ce. Collections agency must not intrude on your relationship with your patient. If you choose so, you should be able to maintain continuous control of patient's account, including negotiation of payment plans or dispute resolution directly with your patient as a key element of the collection process.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen eneration. Generally, the procedure to collect a debt starts with a letter to the person that owes the money sent on the letterhead of collections agency or attorney firm. A letter from an attorney often results in many outstanding debts paid. Flat fees for sending such letters vary between $5 and $15 per patient per month.
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel If the letter does not result in payment, the collections agency must begin vigorous pursuit for outstanding monies. If payment is still not made on the outstanding invoice, a complaint is filed with the courts and served personally upon the debtor requiring their appearance in court. The attorney then appears in court on behalf of medical practice to obtain an award of the amount that is owed. Al ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust though the court usually enters an award on behalf of medical practice, it is important to note that collections are not completed at the time of award. The collections agency must continue to pursue payment of all debts through any and all legal means available, including wage garnishment, bank account seizures, or, in rare cases, arrest. Success fees vary from 30% to 50% of recovered debt.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products li> Even Focus Regardless of Balance Size. Collections solution must be effective for all balances regardless of amount owed.
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip billing service from remaining collections process and any associated fees.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Job Trend News: Home and Workplace Blur Consultants And Getting The Most Value Added - When and How to Use Consultants Cost Effectively Improve Networking Group Effectiveness with Member's Experiences
|